Conclusion
T2D
CORONARY ARTERY DISEASE, HYPERPLASIA
In this assessor blinded, randomized trial we found no evidence of a favorable effect of exenatide neither on strut coverage of a modern DES, nor on the occurrence of neo-intima hyperplasia, or neo-atherosclerosis in subjects with T2D and coronary artery disease.